CEREVEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cerevel Therapeutics - CEREBusiness Wire • Friday
Looking for Dividend Growth in the New Year? 3 Magnificent Stocks to Buy Now.The Motley Fool • Thursday
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience PipelinePRNewsWire • Wednesday
Exclusive: AbbVie nears roughly $8 billion deal for drug developer Cerevel-sourcesReuters • Wednesday
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • Tuesday
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic AntibodiesPRNewsWire • Tuesday
IMMUNOGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ImmunoGen, Inc. - IMGNBusiness Wire • Tuesday